{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:19:31Z","timestamp":1762265971903,"version":"build-2065373602"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004784","name":"Novartis Foundation for Medical-Biological Research","doi-asserted-by":"publisher","award":["22A074"],"award-info":[{"award-number":["22A074"]}],"id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PE00000007","COC-1- 2023-CNR"],"award-info":[{"award-number":["PE00000007","COC-1- 2023-CNR"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["24448","20762"],"award-info":[{"award-number":["24448","20762"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008273","name":"Novartis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118098","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T02:27:58Z","timestamp":1756434478000},"page":"118098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Developing Type II F508del-CFTR correctors with a protective effect against respiratory viruses"],"prefix":"10.1016","volume":"300","author":[{"given":"Francesca","family":"Barbieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Martina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noemi","family":"Cabella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuele","family":"Crespan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Gemma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Campiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Milite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Campiglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Sbardella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Maga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Cagno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Pedemonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0874-6697","authenticated-orcid":false,"given":"Marco","family":"Radi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118098_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3390\/genes11060589","article-title":"The changing epidemiology of cystic fibrosis: incidence, survival and impact of the CFTR gene discovery","volume":"11","author":"Scotet","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.ejmech.2025.118098_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcte.2024.100344","article-title":"Racial inequities and rare CFTR variants: impact on cystic fibrosis diagnosis and treatment","volume":"36","author":"Wu","year":"2024","journal-title":"Journal of Clinical & Translational Endocrinology"},{"key":"10.1016\/j.ejmech.2025.118098_bib3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejmech.2025.118098_bib4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies for cystic fibrosis","volume":"4","author":"De Boeck","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ejmech.2025.118098_bib5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","article-title":"From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations","volume":"27","author":"Veit","year":"2016","journal-title":"MBoC"},{"key":"10.1016\/j.ejmech.2025.118098_bib6","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.118098_bib7","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMra0910061","article-title":"Airway mucus function and dysfunction","volume":"363","author":"Fahy","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.118098_bib8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/thoraxjnl-2013-203204","article-title":"Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications","volume":"68","author":"Cohen-Cymberknoh","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.ejmech.2025.118098_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jcf.2007.12.002","article-title":"The role of respiratory viruses in cystic fibrosis","volume":"7","author":"Wat","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejmech.2025.118098_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ppul.24246","article-title":"Airway microenvironment alterations and pathogen growth in cystic fibrosis","volume":"54","author":"Rossi","year":"2019","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ejmech.2025.118098_bib11","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/jpids\/piac061","article-title":"Drugs, drugs, drugs: current treatment paradigms in cystic fibrosis airway infections","volume":"11","author":"Cogen","year":"2022","journal-title":"Journal of the Pediatric Infectious Diseases Society"},{"key":"10.1016\/j.ejmech.2025.118098_bib12","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/ppul.24061","article-title":"Treatment complexity in cystic fibrosis (CF): an increasing multifaceted challenge","volume":"53","author":"Phan","year":"2018","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ejmech.2025.118098_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102239","article-title":"Current state of CFTR modulators for treatment of Cystic fibrosis","volume":"65","author":"Despotes","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118098_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/ph16030410","article-title":"Elexacaftor-Tezacaftor-Ivacaftor: a life-changing triple combination of CFTR modulator drugs for cystic fibrosis","volume":"16","author":"Bacalhau","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.118098_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1126\/science.ade2216","article-title":"Molecular structures reveal synergistic rescue of \u0394508 CFTR by Trikafta modulators","volume":"378","author":"Fiedorczuk","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118098_bib16","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1172\/JCI24898","article-title":"Small-molecule correctors of defective F508-CFTR cellular processing identified by high-throughput screening","volume":"115","author":"Pedemonte","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.118098_bib17","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1021\/jm5007885","article-title":"Constrained bithiazoles: small molecule correctors of defective \u0394F508\u2013CFTR protein trafficking","volume":"57","author":"Coffman","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118098_bib18","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1183\/23120541.00716-2021","article-title":"Novel CFTR modulator combinations maximise rescue of G85E and N1303K in rectal organoids","volume":"8","author":"Ensinck","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.ejmech.2025.118098_bib19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ppul.25459","article-title":"Cystic fibrosis year in review 2020: section 2 pulmonary disease, infections, and inflammation","volume":"57","author":"Antos","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ejmech.2025.118098_bib20","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/1040841X.2017.1297763","article-title":"Viruses in cystic fibrosis patients' airways","volume":"43","author":"Billard","year":"2017","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2025.118098_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jcv.2014.02.005","article-title":"Virus and cystic fibrosis: rhinoviruses are associated with exacerbations in adult patients","volume":"60","author":"Goffard","year":"2014","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ejmech.2025.118098_bib22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/genes11050536","article-title":"The microbiome in cystic fibrosis pulmonary disease","volume":"11","author":"Fran\u00e7oise","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.ejmech.2025.118098_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2019.105854","article-title":"Respiratory viral infections in Western Australians with cystic fibrosis","volume":"161","author":"Brestovac","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.ejmech.2025.118098_bib24","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.3390\/ijms24044052","article-title":"Respiratory infection and inflammation in cystic fibrosis: a dynamic interplay among the host, microbes, and environment for the ages","volume":"24","author":"Yu","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.ejmech.2025.118098_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104478","article-title":"The role of rhinovirus infections in young children with cystic fibrosis","volume":"129","author":"O Loughlin","year":"2020","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ejmech.2025.118098_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12985-019-1208-7","article-title":"Viral respiratory tract infections in young children with cystic fibrosis: a prospective full-year seasonal study","volume":"16","author":"Eymery","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.ejmech.2025.118098_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240452","article-title":"Clinical impact of respiratory virus in pulmonary exacerbations of children with Cystic Fibrosis","volume":"15","author":"Meyer","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118098_bib28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jcf.2012.04.006","article-title":"Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis","volume":"11","author":"Asner","year":"2012","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejmech.2025.118098_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2016.11.004","article-title":"Multiplex PCR reveals that viruses are more frequent than bacteria in children with cystic fibrosis","volume":"86","author":"Mir\u00f3-Ca\u00f1\u00eds","year":"2017","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ejmech.2025.118098_bib30","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/genes12060803","article-title":"Quantification of phenotypic variability of lung disease in children with cystic fibrosis","volume":"12","author":"Stahl","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.ejmech.2025.118098_bib31","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1073\/pnas.1516979113","article-title":"Respiratory syncytial virus infection enhances Pseudomonas aeruginosa biofilm growth through dysregulation of nutritional immunity","volume":"113","author":"Hendricks","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2025.118098_bib32","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1183\/09031936.00102014","article-title":"Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells","volume":"45","author":"Sch\u00f6gler","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejmech.2025.118098_bib33","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1128\/JVI.01864-15","article-title":"Digging through the obstruction: insight into the epithelial cell response to respiratory virus infection in patients with cystic fibrosis","volume":"90","author":"Hendricks","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2025.118098_bib34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcf.2015.10.013","article-title":"Interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection","volume":"15","author":"Sch\u00f6gler","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejmech.2025.118098_bib35","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3389\/fimmu.2020.01327","article-title":"Rhinovirus infection drives complex host airway molecular responses in children with cystic fibrosis","volume":"11","author":"Ling","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.118098_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/17476348.2017.1288102","article-title":"The diagnosis and management of respiratory viral infections in cystic fibrosis","volume":"11","author":"Flight","year":"2017","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.ejmech.2025.118098_bib37","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3389\/fphar.2018.01270","article-title":"WAERP, AusREC, Australian respiratory early surveillance team for cystic fibrosis, elucidating the interaction of CF airway epithelial cells and rhinovirus: using the host-pathogen relationship to identify future therapeutic strategies","volume":"9","author":"Ling","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118098_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106055","article-title":"Polypharmacology: the science of multi-targeting molecules","volume":"176","author":"Kabir","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.118098_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ppul.23505","article-title":"Therapeutic challenges posed by critical drug\u2013drug interactions in cystic fibrosis","volume":"51","author":"Jordan","year":"2016","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ejmech.2025.118098_bib40","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1021\/acs.jmedchem.6b01521","article-title":"Discovery of multitarget agents active as broad-spectrum antivirals and correctors of cystic fibrosis transmembrane conductance regulator for associated pulmonary diseases","volume":"60","author":"Tassini","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118098_bib41","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1021\/acs.jmedchem.9b01416","article-title":"Multitarget CFTR modulators endowed with multiple beneficial side effects for cystic fibrosis patients: toward a simplified therapeutic approach","volume":"62","author":"Tassini","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118098_bib42","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1002\/cmdc.202100483","article-title":"Bithiazole inhibitors of phosphatidylinositol 4\u2010Kinase (PI4KIII\u03b2) as broad\u2010spectrum antivirals blocking the replication of SARS\u2010CoV\u20102, zika virus, and human rhinoviruses","volume":"16","author":"Grazia Martina","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118098_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.106003","article-title":"Bithiazole inhibitors of PI4KB show broad-spectrum antiviral activity against different viral families","volume":"231","author":"Martina","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.118098_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200277","article-title":"Towards innovative antibacterial correctors for cystic fibrosis targeting the lung microbiome with a multifunctional effect","volume":"17","author":"Martina","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118098_bib45","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1021\/jm800533c","article-title":"Potent s-cis -Locked bithiazole correctors of \u0394F508 cystic fibrosis transmembrane conductance regulator cellular processing for cystic fibrosis therapy","volume":"51","author":"Yu","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118098_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116501","article-title":"Macrocyclization strategy for improving candidate profiles in medicinal chemistry","volume":"272","author":"Darlami","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118098_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.641059","article-title":"Electrostatic interaction between NS1 and negatively charged lipids contributes to flavivirus replication organelles formation","volume":"12","author":"Ci","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2025.118098_bib48","doi-asserted-by":"crossref","first-page":"8457","DOI":"10.1074\/jbc.M111.312561","article-title":"Phosphatidylinositol 4-Kinase III\u03b2 is required for severe acute respiratory syndrome coronavirus spike-mediated cell entry","volume":"287","author":"Yang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118098_bib49","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm970530e","article-title":"Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes","volume":"41","author":"Kansy","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118098_bib50","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1021\/jm5019687","article-title":"A novel cell-permeable, selective, and noncompetitive inhibitor of KAT3 histone acetyltransferases from a combined molecular pruning\/classical isosterism approach","volume":"58","author":"Milite","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118098_bib51","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1021\/acs.jmedchem.8b02008","article-title":"Discovery of a novel chemotype of histone lysine methyltransferase EHMT1\/2 (GLP\/G9a) inhibitors: rational design, synthesis, biological evaluation, and Co-crystal structure","volume":"62","author":"Milite","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118098_bib52","doi-asserted-by":"crossref","first-page":"11574","DOI":"10.1021\/acs.jmedchem.2c00252","article-title":"Turning nonselective inhibitors of type I protein arginine methyltransferases into potent and selective inhibitors of protein arginine methyltransferase 4 through a deconstruction\u2013reconstruction and fragment-growing approach","volume":"65","author":"Iannelli","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118098_bib53","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1021\/jm001020e","article-title":"High-throughput permeability pH profile and high-throughput alkane\/water log P with artificial membranes","volume":"44","author":"Wohnsland","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118098_bib54","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/jps.21068","article-title":"PAMPA\u2014Critical factors for better predictions of absorption","volume":"96","author":"Avdeef","year":"2007","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2025.118098_bib55","series-title":"Dosage Forms - Innovation and Future Perspectives","article-title":"In vitro drug metabolism studies using human liver microsomes","author":"Gajula","year":"2022"},{"key":"10.1016\/j.ejmech.2025.118098_bib56","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/1087057103255988","article-title":"Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates","volume":"8","author":"Di","year":"2003","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejmech.2025.118098_bib57","series-title":"Cytochrome P450","first-page":"229","article-title":"Cytochrome P450-Mediated metabolic stability assay in liver microsomes","author":"Carione","year":"2021"},{"key":"10.1016\/j.ejmech.2025.118098_bib58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/adt.2007.103","article-title":"An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion","volume":"6","author":"McNaney","year":"2008","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ejmech.2025.118098_bib59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/acs.jmedchem.9b00796","article-title":"Synthesis and pharmacological characterization of conformationally restricted retigabine analogues as novel neuronal Kv7 channel activators","volume":"63","author":"Ostacolo","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118098_bib60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12936-021-03617-1","article-title":"Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones","volume":"20","author":"Chen","year":"2021","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2025.118098_bib61","doi-asserted-by":"crossref","first-page":"C872","DOI":"10.1152\/ajpcell.00507.2010","article-title":"Rescue of the mutant CFTR chloride channel by pharmacological correctors and low temperature analyzed by gene expression profiling","volume":"301","author":"Sondo","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejmech.2025.118098_bib62","doi-asserted-by":"crossref","first-page":"C866","DOI":"10.1152\/ajpcell.00404.2009","article-title":"Influence of cell background on pharmacological rescue of mutant CFTR","volume":"298","author":"Pedemonte","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:15:35Z","timestamp":1762265735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425008633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":62,"alternative-id":["S0223523425008633"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118098","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing Type II F508del-CFTR correctors with a protective effect against respiratory viruses","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118098"}}